This is the authors' abstract. We don't add key points for this paper.
Accurate quantification of SARS-CoV-2-specific antibodies can be achieved using a universal standard with sample dilution within the linear range. With hybrid immunity being now common, it is critical to use protocols adapted to high Ab levels to standardize serological results. We validated this approach with the Los Angeles Pandemic Surveillance Cohort by comparing the antibody decay rates in vaccinated participants and vaccinated infected participants.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pernet et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: